Raku Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
May 11, 2022
Share
Raku Co., Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 98.4 million compared to TWD 110.39 million a year ago. Revenue was TWD 98.4 million compared to TWD 110.39 million a year ago. Net loss was TWD 3.92 million compared to TWD 22.9 million a year ago. Basic loss per share from continuing operations was TWD 0.11 compared to TWD 0.77 a year ago.
Raku Co Ltd, formerly Kino Biotech Co., Ltd., is a Singapore-based company. The Company is an integrated bio-nutraceutical and cosmeceutical company. The Company is focused on product conceptualization, development, commercialization, brand marketing, sale and distribution of healthcare and beauty products. The Company provides healthcare and beauty products and services through brands, including Kinohimitsu, Activa and Xpertise. It has over two logistic and distribution centers in Malaysia and China. The Company provides products to China, Singapore, Malaysia, Vietnam, Thailand and Indonesia.